secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001213900-26-034902
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix implements 1-for-5 reverse stock split to maintain Nasdaq compliance
------------------------------------------------------------------------------

- Reverse stock split effective March 25, 2026 at 12:01 a.m. Eastern Time.
- Ratio fixed at 1-for-5, reducing outstanding shares from ~3.6M to ~0.7M.
- No fractional shares issued; cash compensation based on March 24 closing price.
- CUSIP changes to 68237Q 302; stock trades under symbol ONCO on Nasdaq.
- Split intended to meet Nasdaq's $1.00 minimum bid price listing requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026034902/0001213900-26-034902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026034902/ea0283569-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-034902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer